673
Participants
Start Date
April 14, 2014
Primary Completion Date
May 24, 2023
Study Completion Date
May 24, 2023
Trastuzumab
Trastuzumab will be administered as per the schedule specified in the respective arm, until tumor progression or occurrence of unacceptable toxicity.
Pertuzumab
Pertuzumab will be administered as per the schedule specified in the respective arm, until tumor progression or occurrence of unacceptable toxicity.
Erlotinib
Erlotinib will be administered as per the schedule specified in the respective arm, until tumor progression or occurrence of unacceptable toxicity.
Vemurafenib
Vemurafenib will be administered as per the schedule specified in the respective arm, until tumor progression or occurrence of unacceptable toxicity.
Cobimetinib
Cobimetinib will be administered as per the schedule specified in the respective arm, until tumor progression or occurrence of unacceptable toxicity.
Vismodegib
Vismodegib will be administered as per the schedule specified in the respective arm, until tumor progression or occurrence of unacceptable toxicity.
Alectinib
Alectinib will be administered as per the schedule specified in the respective arm, until tumor progression or occurrence of unacceptable toxicity.
Atezolizumab
Atezolizumab will be administered as per the schedule specified in the respective arm, until tumor progression or occurrence of unacceptable toxicity.
Weill Cornell Univ Medical Ctr; Breast Cancer Center, New York
Herbert Irving Comprehensive Cancer Center; Herbert Irving Pavillion, New York
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center at Westchester, Harrison
UPMC - Hillman Cancer Center, Pittsburgh
Abington Mem Hosp-Abington; Rose. Can Ctr,Gyn Onc Ins, Willow Grove
Abramson Cancer Center, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
Eastern Regional Medical Ctr, Philadelphia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Virginia Cancer Institute, Richmond
Wake Forest Univ Health Svcs; Internal Medicine, Winston-Salem
Duke University Medical Center, Durham
Southeastern Regional Medical Center, Inc., Newnan
Northeast Georgia Medical Center; Oncology Research Dept-5C, Gainesville
University Cancer & Blood Center, LLC; Research, Athens
Mayo Clinic, Jacksonville
Florida Hospital Cancer Inst; Memorial System Onc Clin Rsch, Orlando
Florida Cancer Specialists, Research Department, West Palm Beach
Florida Cancer Specialist, North Region, St. Petersburg
SCRI Florida Cancer Specialists South, Fort Myers
Tennessee Oncology - Nashville, Nashville
Vanderbilt Ingram Cancer Clinic, Nashville
Sarah Cannon Research Institute / Tennessee Oncology, Chattanooga
Tennessee Cancer Specialists, Knoxville
West Clinic, Germantown
Cleveland Clinic, Cleveland
University Hospitals of Cleveland, Cleveland
Oncology Hematology Care Inc, Cincinnati
Medical College of Wisconsin, Milwaukee
University of Wisconsin, Madison
Mayo Foundation, Rochester
Sanford Cancer Cnt Onco Clinic, Sioux Falls
Sanford Roger Maris Cancer Center, Fargo
Midwestern Regional Med Center, Zion
Northwestern University; Robert H. Lurie Comp Can Ctr; Northwestern Medicine Development Inst, Chicago
University Of Chicago Medical Center; Section Of Hematology/Oncology, Chicago
Research Medical Center - Antibiotic Research Associates, Inc., Kansas City
Highlands Oncology Group, Springdale
University of Oklahoma Health Sciences Center, Oklahoma City
The Center for Cancer and Blood Disorders - Fort Worth, Fort Worth
MD Anderson, Houston
Mayo Clinic Arizona, Phoenix
Western Regional Medical Center at Cancer Treatment Centers of America, Goodyear
University of New Mexico Comprehensive Cancer Center, Albuquerque
University of New Mexico Comprehensive Cancer Center - Albuquerque Cedar Street; Drug Shipment, Albuquerque
University of New Mexico Comprehensive Cancer Center - Albuquerque Lang NE; Drug Shipment, Albuquerque
University of New Mexico, Albuquerque
San Juan Oncology Associates, Farmington
Science 37, Inc, Culver City
City of Hope Comprehensive Cancer Center, Duarte
Eisenhower Medical Center, Rancho Mirage
Stanford Comprehensive Cancer Center, Stanford
Kaiser Permanente - Vallejo, Vallejo
Providence Portland Medical Center, Portland
Northwest Medical Specialties, Tacoma
Moores UCSD Cancer Center; Dept Clinical Trials Office, La Jolla
University of Colorado, Aurora
Memorial Sloan Kettering - Monmouth, Middletown
Univ No Carolina School of Med; Physicians Office Bldg, Chapel Hill
Lead Sponsor
Genentech, Inc.
INDUSTRY